Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
RG Hart, LA Pearce, MI Aguilar - Annals of internal medicine, 2007 - acpjournals.org
Background: Atrial fibrillation is a strong independent risk factor for stroke. Purpose: To
characterize the efficacy and safety of antithrombotic agents for stroke prevention in patients …
characterize the efficacy and safety of antithrombotic agents for stroke prevention in patients …
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the …
V Fuster, LE Rydén, DS Cannom, HJ Crijns… - Journal of the American …, 2011 - jacc.org
1.1. Organization of Committee and Evidence Review (UPDATED) For new or updated text,
view the 2011 Focused Update and the 2011 Update on Dabigatran. Text supporting …
view the 2011 Focused Update and the 2011 Update on Dabigatran. Text supporting …
2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing …
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association
JF Meschia, C Bushnell, B Boden-Albala, LT Braun… - Stroke, 2014 - Am Heart Assoc
The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of stroke among individuals who have not previously …
recommendations on the prevention of stroke among individuals who have not previously …
PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the …
P Khairy, GF Van Hare, S Balaji, CI Berul… - Heart …, 2014 - heartrhythmjournal.com
4. Delivery of care and ensuring access to care.............. e108 4.1. Recommendations for the
coordination and delivery of care for adults with CHD and arrhythmias …
coordination and delivery of care for adults with CHD and arrhythmias …
Heart disease and stroke statistics—2011 update: a report from the American Heart Association
VL Roger, AS Go, DM Lloyd-Jones, RJ Adams… - Circulation, 2011 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …
for Disease Control and Prevention, the National Institutes of Health, and other government …
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
LB Goldstein, CD Bushnell, RJ Adams, LJ Appel… - Stroke, 2011 - Am Heart Assoc
Background and Purpose—This guideline provides an overview of the evidence on
established and emerging risk factors for stroke to provide evidence-based …
established and emerging risk factors for stroke to provide evidence-based …
Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical …
Background The risk of stroke varies considerably across different groups of patients with
atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is associated with an increased …
atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is associated with an increased …
Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE registry
Importance Patients with atrial fibrillation (AF) are at a proportionally higher risk of stroke
based on accumulation of well-defined risk factors. Objective To examine the extent to which …
based on accumulation of well-defined risk factors. Objective To examine the extent to which …
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
ML Hansen, R Sørensen, MT Clausen… - Archives of internal …, 2010 - jamanetwork.com
Background Patients with atrial fibrillation (AF) often require anticoagulation and platelet
inhibition, but data are limited on the bleeding risk of combination therapy. Methods We …
inhibition, but data are limited on the bleeding risk of combination therapy. Methods We …